Bifurcation Lesions Market Seen Reaching $4.34 Billion by 2030

The bifurcation lesions market is projected to grow from $2.84 billion in 2025 to $3.1 billion in 2026, with further expansion to $4.34 billion by 2030, according to a new report from The Business Research Company. Demand is being driven by rising coronary artery disease cases, wider use of interventional cardiology, and advances in stenting and imaging-guided procedures.

Why it matters: - The bifurcation lesions market sits at the intersection of coronary artery disease treatment and advanced interventional cardiology. - Faster growth could increase demand for specialized stents, imaging tools and minimally invasive procedures that improve treatment for complex heart lesions. - Healthcare systems are investing more in equipment and technology, which supports adoption of advanced devices for these procedures.

What happened: - The Business Research Company released its Bifurcation Lesions Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035. - The report projects the market will rise from $2.84 billion in 2025 to $3.1 billion in 2026, a 9.4% CAGR. - The report forecasts the market will reach $4.34 billion by 2030, with an 8.7% CAGR over that period. - The company also published a free sample report and a full report.

The details: - Bifurcation lesions are narrowings that form at or near the origin of a side branch of a coronary artery. - Plaque buildup reduces the artery’s diameter and limits blood flow to the heart muscle. - Preserving the side branch makes treatment more complex and requires specialized stents and precise interventional techniques. - Growth through 2026 was driven by rising coronary artery disease prevalence, broader use of interventional cardiology, a shift from surgical bypass to stenting, availability of specialized bifurcation stents and improved clinical skills. - Future growth is expected to come from precision-guided coronary interventions, next-generation stent technologies, personalized cardiovascular therapies, broader use of imaging and analytics and a stronger focus on procedural success. - Key trends include more advanced stent techniques for complex lesions, greater use of imaging-guided interventions, preference for drug-eluting stents, growth in minimally invasive coronary procedures and a focus on keeping vessels open over the long term. - Rising healthcare spending is another support factor because larger budgets can fund advanced interventional cardiology devices. - The UK’s Office for National Statistics reported a 5.6% nominal increase in total healthcare spending in 2023 in May 2024, a 0.9% rise from the previous year.

Between the lines: - The forecast suggests the market is moving from broad procedure growth toward more specialized, technology-driven treatment approaches. - North America held the largest market share in 2025, reflecting established healthcare infrastructure and early adoption of advanced medical technology. - Asia-Pacific is expected to be the fastest-growing region as demand expands across more healthcare systems. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report includes new additions such as market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis.

What's next: - The market is expected to keep growing as hospitals and cardiology specialists adopt more precise and less invasive treatment methods. - The company’s regional and segment analysis points to continued opportunity in Asia-Pacific and in technologies that improve procedural success and long-term vessel patency. - More information is available through the company’s LinkedIn page.